Lund Systemic Sclerosis Research Group
31 – 40 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Multiple manifestations of systemic sclerosis affect walk distance
- Contribution to journal › Letter
-
Mark
Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
- Contribution to journal › Scientific review
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
- Contribution to journal › Article
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
- Contribution to journal › Article
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
- Contribution to journal › Article
- 2020
-
Mark
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy : a registry-based study
- Contribution to journal › Article
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
- Contribution to journal › Article
-
Mark
Mixed airway and pulmonary parenchymal disease in patients with primary Sjögren's Syndrome - a six-year follow-up
- Contribution to journal › Article
-
Mark
Validity and reliability of the Patient Health Questionnaire-8 in Swedish for individuals with systemic sclerosis
- Contribution to journal › Article
